HIV - Pre-exposure Prophylaxis (PrEP): Key Clinical Trials
5 Jul, 16
PrEP is the use of an antiretroviral medication by a HIV-negative individuals to prevent them from acquiring HIV. These slides give an overview of the key clinical trials in PrEP which demonstrate that TDF/FTC for PrEP is safe and effective.
Related Slideshows
Related Topics